Crisis and Change


The COVID-19 Vaccines Global Access, more well-known for its other name COVAX, was designed for the purpose of equitable vaccine procurement and distribution across the world. The result was largely loud but immaterial support from wealthier national governments, whose participation was essential for the success of COVAX. In 2022, two years after COVAX was launched, vaccine distributions are still far from equitable, as the majority of vaccine supplies were purchased by wealthy nations well before COVAX was able to procure any substantial amount for itself. This article explores the global pandemic reality, the particular mechanism of COVAX, and the saddening international development that led to the status quo. The article ends with commentaries on the current state of international politics and the direction of our human will and civilization.